BRAIN Biotech AG (LON:0RFI)

Market Cap	55.39M +43.0%
Revenue (ttm)	42.18M -9.7%
Net Income	-9.62M
EPS	-0.45
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Open	2.900
Previous Close	2.910
Day's Range	2.900 - 2.900
52-Week Range	1.810 - 3.900
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About Sampath Bank

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry. The company offers enzymes, biocatalysts, microorganisms, and other bio...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1993
• Employees: 292
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RFI

Financial Performance

In fiscal year 2025, BRAIN Biotech AG's revenue was 50.22 million, a decrease of -9.52% compared to the previous year's 55.50 million. Losses were -11.74 million, 5.53% more than in 2024.